TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33022010

Group type: EXPERIMENTAL
Intervention: Midwifery continuity of care (POPPIE group)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 334
Study: 33358148

Group type: EXPERIMENTAL
Intervention: High Intensive Intervention (HI, n = 63)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Moderate Intensive Intervention (MI, n = 62)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Low Intensive Intervention (LI, n = 63)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: High Intensive Intervention (HI)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Moderate Intensive Intervention (MI)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Low Intensive Intervention (LI)
Number of subjects: 188

Group type: COMPARATOR
Intervention: All groups (HI, MI, LI)
Number of subjects: 188
Study: 33228097

Group type: EXPERIMENTAL
Intervention: Teaching intervention 1 (TI‐1): integrating the concept of contour lines into practical sessions of acrobatic gymnastics
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Teaching intervention 2 (TI‐2): theoretical sessions regarding contour lines
Number of subjects: 238

Group type: COMPARATOR
Intervention: Active control (AC): reading an introductory text about topographic maps
Number of subjects: 238

Group type: COMPARATOR
Intervention: Passive control 1 (PC‐1)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Passive control 2 (PC‐2)
Number of subjects: 238
Study: 34971975

Group type: EXPERIMENTAL
Intervention: WM updating training
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 73
Study: 32993142

Group type: EXPERIMENTAL
Intervention: Adjustable sit-stand desk
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional furniture (control)
Number of subjects: 60
Study: 35282464

Group type: EXPERIMENTAL
Intervention: Time Restricted Eating (TRE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Prolonged eating window (Control)
Number of subjects: 50
Study: 33143264

Group type: EXPERIMENTAL
Intervention: High-SES menus
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low-SES menus
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All menus
Number of subjects: 45
Study: 34404270

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328
Study: 32154732

Group type: EXPERIMENTAL
Intervention: Public education messages (three newly developed messages)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control (no message)
Number of subjects: 152
Study: 35886214

Group type: EXPERIMENTAL
Intervention: Real-world data (RWD) and real-world evidence (RWE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electronic health records (EHRs)
Number of subjects: 0
Study: 33611899

Group type: EXPERIMENTAL
Intervention: IVUS guided stent implantation in CKD group
Number of subjects: 1443

Group type: COMPARATOR
Intervention: Angiography guided stent implantation in CKD group
Number of subjects: 1443

Group type: EXPERIMENTAL
Intervention: IVUS guided stent implantation in non-CKD group
Number of subjects: 1443

Group type: COMPARATOR
Intervention: Angiography guided stent implantation in non-CKD group
Number of subjects: 1443
Study: 36151602

Group type: EXPERIMENTAL
Intervention: Individualized dietary counselling on scheduled appointments throughout 6 months of follow-up
Number of subjects: 62

Group type: COMPARATOR
Intervention: Informative dietary guidelines at baseline
Number of subjects: 62
Study: 34325540

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938/ATCC 5289 for 28 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Tablets without any bacteria (Control)
Number of subjects: 27
Study: 35038254

Group type: EXPERIMENTAL
Intervention: RTD re‐access kit (Composipost, RTD, France, St Egreve) in a conventional hand‐piece driven by an electric motor (Group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Long tapered diamond bur (FG Diamond grit bur, Dentsply Ltd, UK) in an air‐driven high speed turbine (Group B)
Number of subjects: 20
Study: 32949786

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir for 8 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir for 12 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (both durations)
Number of subjects: 100
Study: 35804937

Group type: EXPERIMENTAL
Intervention: Primary care-based follow-up
Number of subjects: 402

Group type: COMPARATOR
Intervention: Specialist-based follow-up
Number of subjects: 402
Study: 32576868

Group type: EXPERIMENTAL
Intervention: hsa_circ_0005548
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: hsa_circ_0000607
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: hsa_circ_0002465
Number of subjects: 6

Group type: COMPARATOR
Intervention: DE circRNAs
Number of subjects: 6

Group type: COMPARATOR
Intervention: Bioinformatic analysis
Number of subjects: 6
Study: 35397772

Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg/day)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 388
Study: 33274772

Group type: EXPERIMENTAL
Intervention: Self-efficacy theory-based parental eczema education program
Number of subjects: 136
Study: 36108911

Group type: EXPERIMENTAL
Intervention: Florajen3 probiotic
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 34339227

Group type: EXPERIMENTAL
Intervention: Discontinuing β-lactam treatment after 3 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuing β-lactam treatment for 5 additional days
Number of subjects: 0
Study: 35386854

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.280 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.200 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.140 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.070 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.100 mg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 120
Study: 33839634

Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's right side with right hand chest contact (RsRc)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's left side with left hand chest contact (LsLc)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's left side with right hand chest contact (LsRc)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's right side with left hand chest contact (RsLc)
Number of subjects: 60
Study: 32406608

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) with 2 mA for 30 min, applied over the supplementary motor area (SMA) and right supraorbital area.
Number of subjects: 21
Study: 35894914

Group type: EXPERIMENTAL
Intervention: Cold-water walk (10-min shower + 20-min walk in cold water)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Cold-water sit (10-min shower + 20-min sit in cold water)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Passive recovery (10-min shower + 20-min passive recovery)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Active recovery (10-min treadmill walk + 10-min static stretch + 10-min shower)
Number of subjects: 17

Group type: COMPARATOR
Intervention: All cooldown strategies
Number of subjects: 17
Study: 33853413

Group type: EXPERIMENTAL
Intervention: Severe erosion (lemon juice/pH 2.5)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Moderate erosion (grapefruit juice/pH 3.5)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No erosion (bottled drinking water, control)
Number of subjects: 20
Study: 32016926

Group type: EXPERIMENTAL
Intervention: Single incision cholecystectomy
Number of subjects: 975
Study: 35898865

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy plus standard medical treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical treatment plus possible local ablative measures (e.g., SBRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life assessments using EORTC QLQ‐C30, QLQ‐CR29 and QLQ‐LC29 questionnaires
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impact of mutational status
Number of subjects: 0
Study: 33170934

Group type: EXPERIMENTAL
Intervention: Azacitidine maintenance (32 mg/m2 per day subcutaneously for 5 days every 28 days for 12 cycles)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Azacitidine maintenance
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 187
Study: 35363600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33992283

Group type: EXPERIMENTAL
Intervention: Knowledge of physical activity guidelines
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Attitude towards physical activity
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Promotion of physical activities in routine practice
Number of subjects: 180
Study: 35211746

Group type: EXPERIMENTAL
Intervention: Parent Training (PT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Psychoeducational dental toolkit (control)
Number of subjects: 119
Study: 33227017

Group type: EXPERIMENTAL
Intervention: Microscopy
Number of subjects: 1870

Group type: EXPERIMENTAL
Intervention: PCR
Number of subjects: 1870

Group type: EXPERIMENTAL
Intervention: P. falciparum mono-infection
Number of subjects: 1870

Group type: EXPERIMENTAL
Intervention: P. falciparum combined with P. malariae
Number of subjects: 1870

Group type: EXPERIMENTAL
Intervention: Overall parasite density
Number of subjects: 1870

Group type: EXPERIMENTAL
Intervention: Gender comparison
Number of subjects: 1870
Study: 35299070

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine
Number of subjects: 295

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study: 32265361

Group type: EXPERIMENTAL
Intervention: Immediate oral etoposide
Number of subjects: 190

Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: No early KS‐PD
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Early KS‐PD
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: KS‐IRIS
Number of subjects: 190
Study: 36057930

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on CT radiomic features
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 220
Study: 33423518

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure control (<140 mm Hg)
Number of subjects: 2839

Group type: EXPERIMENTAL
Intervention: Combination of abnormal physiological parameters and warfarin use
Number of subjects: 2839
Study: 35285972

Group type: EXPERIMENTAL
Intervention: Chinese iSupport for Dementia program (self-learning, virtual peer support, nurse program facilitator support for 6 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chinese iSupport for Dementia program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study: 32788479

Group type: EXPERIMENTAL
Intervention: Infusion giving set
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Burette/Soluset giving set
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Blood giving set
Number of subjects: 215
Study: 34781708

Group type: EXPERIMENTAL
Intervention: Cilostazol (200 mg once daily for 2 years)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Aspirin (100 mg once daily for 2 years)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 256
Study: 34482277

Group type: EXPERIMENTAL
Intervention: Collaborative planning
Number of subjects: 320

Group type: COMPARATOR
Intervention: Individual planning
Number of subjects: 320

Group type: COMPARATOR
Intervention: Dyadic planning
Number of subjects: 320

Group type: COMPARATOR
Intervention: Active (education) control
Number of subjects: 320
Study: 34711261

Group type: EXPERIMENTAL
Intervention: Mentalization-based parenting-counseling (MB-PC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced standard clinical care (SCC+)
Number of subjects: 0
Study: 33044838

Group type: EXPERIMENTAL
Intervention: Iliotibial Band (ITB) Reconstruction
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Achilles Tendon Reconstruction
Number of subjects: 16

Group type: COMPARATOR
Intervention: Capsulectomy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Reconstruction (both techniques)
Number of subjects: 16
Study: 36066107

Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation
Number of subjects: 1224

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation
Number of subjects: 1224

Group type: EXPERIMENTAL
Intervention: Pressure-control with volume guaranteed ventilation
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1224
Study: 33829990

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFA)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Multiple procedures (RFA)
Number of subjects: 304
Study: 32083603

Group type: EXPERIMENTAL
Intervention: Cognitive dysfunction measured at hospital discharge
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Social disadaptation measured at hospital discharge
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Baseline cognitive dysfunction
Number of subjects: 109
Study: 36145139

Group type: EXPERIMENTAL
Intervention: C. longa extract group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 90
Study: 33297730

Group type: EXPERIMENTAL
Intervention: Psychoeducational relaxation therapy (PRT, n=84)
Number of subjects: 138
Study: 36169957

Group type: EXPERIMENTAL
Intervention: Electronic interprofessional‐led discharge planning tool
Number of subjects: 54695

Group type: COMPARATOR
Intervention: Standard discharge planning
Number of subjects: 54695
Study: 33892316

Group type: EXPERIMENTAL
Intervention: Trastuzumab-dkst
Number of subjects: 500

Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 500
Study: 33307218

Group type: EXPERIMENTAL
Intervention: GA area growth rate
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: GA perimeter‐adjusted growth rate
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: GA perimeter‐adjusted growth rate in eyes with fellow eyes showing GA
Number of subjects: 318

Group type: COMPARATOR
Intervention: GA perimeter‐adjusted growth rate in eyes with fellow eyes never demonstrating GA
Number of subjects: 318
Study: 33017328

Group type: EXPERIMENTAL
Intervention: Training program based on Orem's self‐care deficit nursing theory (SCDNT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 102
Study: 37125984

Group type: EXPERIMENTAL
Intervention: School-based pregnancy prevention intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 33432503

Group type: EXPERIMENTAL
Intervention: Near-infrared autofluorescence imaging (NIRAF)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No near-infrared autofluorescence imaging (NONIR)
Number of subjects: 180
Study: 32459637

Group type: EXPERIMENTAL
Intervention: Digital telereview (asynchronous and synchronous format)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Telephone-based telereview (control)
Number of subjects: 70
Study: 35470104

Group type: EXPERIMENTAL
Intervention: Stress First Aid (SFA)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 850
Study: 33512754

Group type: EXPERIMENTAL
Intervention: Licogliflozin (50 mg once daily)
Number of subjects: 53
Study: 35670001

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT) in variable contexts (n=19)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT) focused on forward walking (n=19)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Low-Intensity Variable Training (n=20)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both HIT groups
Number of subjects: 58
Study: 35023598

Group type: EXPERIMENTAL
Intervention: Malleable-prejudice theory story
Number of subjects: 152

Group type: COMPARATOR
Intervention: Fixed-prejudice theory story
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Simulated cross-race interaction
Number of subjects: 152

Group type: COMPARATOR
Intervention: Same-race interaction
Number of subjects: 152
Study: 33075807

Group type: EXPERIMENTAL
Intervention: Kisspeptin (1 nmol/kg/h intravenous infusion over 75 minutes)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Vehicle (rate‐matched infusion)
Number of subjects: 27
Study: 32600452

Group type: EXPERIMENTAL
Intervention: Pegloticase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pegloticase (in open-label extension)
Number of subjects: 0
Study: 35289231

Group type: COMPARATOR
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Bone Marrow Aspirate Concentrate (BMC)
Number of subjects: 90
Study: 32831303

Group type: EXPERIMENTAL
Intervention: Telemetric, gravimetric platform for real-time physiological phenotyping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feedback fertigation system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time analytic tool and online statistical resource
Number of subjects: 0
Study: 33866916

Group type: EXPERIMENTAL
Intervention: Isotretinoin treatment (mean daily dose 38.7 ± 2.8 mg for 7.20 ± 0.79 months)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 25
Study: 35121063

Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Management (GDFM)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Liberal Fluid Management (LFM)
Number of subjects: 104
Study: 32776169

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training for 2 weeks followed by conventional therapy for 2 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional therapy for 2 weeks followed by robot-assisted gait training for 2 weeks
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional therapy followed by robot-assisted gait training
Number of subjects: 63
Study: 32776861

Group type: EXPERIMENTAL
Intervention: Continuous music
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Respite music
Number of subjects: 18

Group type: COMPARATOR
Intervention: No-music control
Number of subjects: 18
Study: 36240389

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: CMAC videolaryngoscope
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Smart Trach laryngoscope
Number of subjects: 375

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 375
Study: 34176638

Group type: EXPERIMENTAL
Intervention: Screw fixation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tightrope fixation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Novel double Endobutton fixation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intact syndesmosis
Number of subjects: 24
Study: 35508683

Group type: EXPERIMENTAL
Intervention: Nomogram model based on the γ‐glutamyl transpeptidase‐to‐albumin ratio (GAR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 0
Study: 33762220

Group type: EXPERIMENTAL
Intervention: γ-tACS
Number of subjects: 20

Group type: COMPARATOR
Intervention: sham tACS
Number of subjects: 20
Study: 35670045

Group type: EXPERIMENTAL
Intervention: Percutaneous needle electrolysis
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 48
Study: 33077012

Group type: EXPERIMENTAL
Intervention: Lurasidone (20-80 mg/day)
Number of subjects: 271
Study: 34031118

Group type: EXPERIMENTAL
Intervention: Enhanced compassion video
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard introduction video
Number of subjects: 0
Study: 35639143

Group type: EXPERIMENTAL
Intervention: Radiomics model based on pretreatment MRI
Number of subjects: 216

Group type: COMPARATOR
Intervention: Clinical prediction model
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Combined radiomics and clinical features model
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Clinical‐radiomics model
Number of subjects: 216
Study: 34780532

Group type: EXPERIMENTAL
Intervention: Supervised exercise (SUP)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Home-based exercise (HB)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Supervised plus home-based exercise (SUP+HB)
Number of subjects: 66
Study: 34881844

Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft (SCTG) followed by orthodontic treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Orthodontic treatment only
Number of subjects: 36
Study: 33270123

Group type: EXPERIMENTAL
Intervention: SLCO1B1 genotyping and results reporting to primary care physicians at baseline (intervention group)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Patients with decreased or poor SLCO1B1 transporter function genotype (intervention group)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Patients with decreased or poor SLCO1B1 transporter function genotype (control group)
Number of subjects: 408
Study: 34184401

Group type: EXPERIMENTAL
Intervention: Low-calorie formula diet (LCD) for 8 weeks
Number of subjects: 162
Study: 32588401

Group type: EXPERIMENTAL
Intervention: Solriamfetol 75 mg
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Solriamfetol 150 mg
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Solriamfetol (combined)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo (cataplexy subgroup)
Number of subjects: 231